As an establishment, you should risk assess your supply chain of reagents and consumables relating to the handling of tissues and cells. You should consider what steps you would take in the event that any tissues, cells or reagents go outside of validated parameters during transit, or in the event that you are unable to access a critical reagent or material.
You should refer to our guidance on the use of alternative reagents and materials for the processing of tissues and cells in the event of supply disruption resulting from the UK exiting the EU. If you have identified any potential risks, please contact us.
NHS establishments should escalate any supply issues in line with established internal reporting mechanisms.
You can also refer to the Government’s latest advice on CE marking.